Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study

Inclusion Criteria: * Ambulatory patients suffering from lower urinary tract symptoms suggestive of BPH. Exclusion Criteria: * Patients requiring BPH surgery immediately or within the 12 following months: * Acute renal obstruction * Chronic renal obstruction * Chronic renal failure from BPH * Bladder stone * Recurrent urinary tract infection * Other bladder pathology such as cancer of the bladder, bladder bidiverticulum (big size) * Hematuria from BPH * Patients whose urinary symptoms are satisfactorily controlled on other BPH medication ( alpha-blockers or 5 alpha-reductase) * Patients previously not improved by an alpha1-blocker treatment * Known hypersensitivity to alfuzosin * History of postural hypotension or syncope * Combination with other alpha1-blockers * Hepatic enzyme (SGOT or/and SGPT ) \> 1.5 Upper Normal Limit * Unstable angina pectoris * Severe concomitant condition threatening life. * Patients who had failed treatment with finasteride (Proscar) * Patients with neuropathic bladder. * Patients with history of previous surgery for BPH * Patients with high risk for prostate cancer based on the clinical judgement of the investigator The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.